Fexofenadine HCl and Pseudoephedrine HCl Articles

Teva returns to profit, as 4th quarter 2009 sales leap 33%

16 February 2010

Sanofi-Aventis' Allegra-D available in USA

8 August 2005

Barr eligible for exclusivity on generic Allegra-D

18 April 2005

Update on Barr/Aventis Allegra patent dispute

11 April 2005

IMPAX intervenes in Barr litigation

7 March 2005

Barr sues FDA over generic Allegra

14 February 2005

Stock Commentary - New York

12 July 2004

Barr and Pfizer win patent litigations

12 July 2004

Aventis files new Allegra patent infringement suits

15 March 2004

Aventis submits NDA for once-daily Alegra

5 January 2004

Labopharm net losses increase in fiscal 2003 1st qtr, but confidence still high

15 July 2002

Unnamed Aventis product terminated

25 March 2002

FDA to review IMPAX ANDA for Allegra-D generic

18 February 2002

Barr and Aventis file suit over Allegra-D patents

4 February 2002

HMR has 10 priority projects in development

22 April 1999

Review Of US Second Qtr & Implications For Euro Firms

20 August 1998

HMR Launches Allegra-D In USA

19 March 1998

HMR Pulls Seldane

2 January 1998

Showing 1-18 of 18 articles

Go to beginningPrevious
  • 1
NextGo to end